Free Trial

Timber Creek Capital Management LLC Makes New $3.34 Million Investment in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Timber Creek Capital Management LLC purchased a new stake in shares of Genpact Limited (NYSE:G - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 77,762 shares of the business services provider's stock, valued at approximately $3,340,000.

A number of other hedge funds have also bought and sold shares of the business. JPMorgan Chase & Co. raised its position in shares of Genpact by 192.8% in the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock valued at $122,701,000 after purchasing an additional 2,060,595 shares during the period. Los Angeles Capital Management LLC bought a new stake in Genpact during the 3rd quarter valued at $19,779,000. Tandem Investment Advisors Inc. purchased a new stake in shares of Genpact during the third quarter worth $17,025,000. Geode Capital Management LLC boosted its holdings in shares of Genpact by 12.6% in the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock worth $148,142,000 after acquiring an additional 413,646 shares during the period. Finally, Empowered Funds LLC grew its position in shares of Genpact by 1,942.3% in the fourth quarter. Empowered Funds LLC now owns 325,379 shares of the business services provider's stock valued at $13,975,000 after purchasing an additional 309,447 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors.

Insider Activity at Genpact

In related news, SVP Piyush Mehta sold 12,000 shares of the company's stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Balkrishan Kalra sold 9,000 shares of the company's stock in a transaction on Monday, November 25th. The stock was sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares of the company's stock, valued at $12,407,545.60. This trade represents a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,600 shares of company stock worth $1,538,120 in the last three months. 2.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have commented on G. Robert W. Baird raised their target price on Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research note on Friday, November 8th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and raised their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Needham & Company LLC boosted their price objective on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and increased their target price for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Mizuho boosted their price target on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $48.44.

Read Our Latest Stock Report on Genpact

Genpact Trading Down 2.3 %

NYSE G traded down $1.28 during trading on Friday, hitting $53.21. 1,745,116 shares of the company's stock traded hands, compared to its average volume of 1,521,421. The stock has a fifty day moving average of $46.83 and a two-hundred day moving average of $42.59. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76. The firm has a market cap of $9.38 billion, a P/E ratio of 18.73, a PEG ratio of 1.85 and a beta of 1.20. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, sell-side analysts expect that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.28%. This is an increase from Genpact's previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. Genpact's payout ratio is presently 21.48%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines